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Who Should Provide Research
Initiative and Support?
by Lewis H. Kuller*
The study of low dose environmental exposure is a major concern for epidemiologists. The
problem is a special example of a common source epidemic with either single or continuous
exposure. Usually the most common source investigations begin with an epidemic, cluster of
cases. However, environmental studies often start with an exposure that is considered to be
potentially hazardous and a search for cases. The relatively low attack rate and also relative
risk requires large sample sizes for testing hypotheses. The incubation period from exposure to
onset of the disease may be very long, and therefore the exposure dose is difficult to define.
Many of the diseases of interest also have multiple etiologies, and the amount of disease
attributed to the specific environmental exposure may be relatively small (the attributable
risk). Many of the other potential etiological agents also share common host characteristics
with the environmental agent ofinterest further confounding the analysis. The identification of
specific, unusual characteristics of disease such as rare histological type or location, or host
characteristic may be a valuable approach to the study of environmental agents. The cost of
doing environmental studies are substantial. Various resources are currently being utilized.
There are several problems associated with many of these nongovernmental resources. One
possible solution to the availability of a large funding source for environmental research,
independent of special interest groups, may be a consumer-oriented tax on adverse personal
health behavior, such as alcohol consumption and cigarette smoking.
Introduction
The interest in this topic, "Who Should Provide
Research Initiative and Support?", evolved from
three observations: (1) The concern by reviewers
of grant proposals related to epidemiological stud-
ies of low dose environmental effects: a fundamen-
tal question has been raised about the utility or
the cost benefit of doing extensive low dose
environmental epidemiological studies when the
results of such studies are likely to be negative or
equivocal. (2) The apparent desire to spend rela-
tively large amounts of money to modify the
environmental problems associated with low dose
effects in the absence of solid evidence of health
risks: the presumed effects on the population at
risk is generally based on health effects at a much
higher dose and the extrapolation of a dose re-
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sponse curve to the low dose effect. (3) The
relative decline in federal support for health re-
lated research and the corresponding increase
dependency on support from special interest groups
such as major industrial concerns, trade organ-
izations, foundations, and lobbyists.
Several groups have recently discussed the need
for epidemiological studies ofenvironmental health
effects. Some of my colleagues in toxicology and
experimental biology have considered the mouse
and rat a close relative to man and have decided
that except for a slight weight adjustment, ex-
trapolation from one species to another is biologi-
cally sound. Others have decided that cell culture
techniques may be a satisfactory replacement for
human observations. I do not believe that a
dialogue about the merits of cell culture, mouse
toxicological studies or even human clinical obser-
vations as compared to epidemiology is useful.
Each approach has a specific merit and must be
used conjointly in order to resolve the complex
problems of the environment and human health. I
81do, however, believe that the ultimate and impor-
tant question is the relationship between a specific
environmental agent and the exposed human, not
necessarily the mouse. Human experimental stud-
ies, such as carefully done clinical trials, or even
laboratory controlled experiments will remain the
gem of the health research area. The trials of
killed poliomyelitis vaccine by Dr. Jonas Salk and
Tommy Francis culminated the years oflaboratory
and observational epidemiological research and
were the beginning of the end of a great health
problem. The fluoridation trials are an important
example of the types of environmental experimen-
tal epidemiological studies which are possible to do
and result in extremely important public health
results.
Why are environmental epidemiological studies
expensive? Why are the results of such studies
often equivocal and confusing? An environmental
epidemiological problem is a special case of a
common source epidemic investigation. We may
either investigate a single exposure, such as the
atomic bomb radiation effects, or a continuous
exposure as in the occupational situation or in the
continuous exposure to air pollutants, or toxic
chemicals. In the classical common source expo-
sure investigation the epidemiologist begins with
an observed epidemic of disease (Table 1). He
notes an increased frequency of disease above that
which would be expected. The distribution of the
disease that is identified is measured in relation to
time and the population at risk. Based on these
observations a common source, rather than person
to person, zoonotic, or other indirect exposure is
suggested. The investigator then begins an inten-
Table 1.
Common source epidemic Environmental exposure
Identification of "epidemics" Unusual level of exposure to
environmental agent
Definition of disease by Identification ofpopulation at
examination of cases risk and exposure dose
1 I
Interview to identify common Measurement ofphysiological
source variable or disease incidence
l I
Comparison of cases and Attempt to adjust for
controls confounding variables
4 I
Identification of specific Verification of "dose effect" in
agents and possible dose- other populations
response relationship
Estimation of "attack rate" or
incidence in total exposed
cohort
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sive effort, the detective work, to determine the
source of the epidemic, agent, and mode of trans-
mission. The investigator begins with cases and
works back to the source. Once the probable
source and agent have been identified only then
does the epidemiologist search for the remaining
potential population at risk. The key to the prob-
lem is often the identification ofthe epidemic, that
is, the surveillance of disease within a population.
The initial investigation is often relatively small
and limited to the cluster of cases identified
initially as the epidemic. The approach is basically
a case control type of study. The careful definition
ofthe case is often also a key to the solution ofthe
puzzle. Similarly, the solution to the problem often
depends on the observation of repeat small com-
mon source outbreaks of similar diseases, rather
than the identification and search for disease
among all exposed. It would be extremely unlikely
for health departments to do a detailed investiga-
tion of all individuals who ate at a C rated
restaurant. An outbreak of gastrointestinal dis-
ease might be traced to a specific restaurant or
food source and ultimately to some specific envi-
ronmental problem at the source.
The success of the investigation is therefore
based on: (1) that the specific disease can be
identified, (2) that the incubation period from
exposure to disease is relatively brief, and (3) that
the common source accounts for a fairly substan-
tial percentage ofall disease being studied, that is,
a high attributable risk. The contrast between the
previously described investigation of a common
source epidemic and many of the current environ-
mental epidemiological studies is apparent. First,
most of the environmental investigations begin
with an exposure, rather than disease outbreak.
The search is really for the epidemic, that is,
disease rather than exposure. Fortunately most
individuals exposed to a disease agent do not
develop clinical disease. The so-called attack rate
will rarely approach 100% unless the dose of the
agent is very great or the pathogenicity of the
agent, that is, ability to cause disease among those
exposed, is severe. Most environmental investiga-
tions therefore require very large sample sizes in
order to identify the relatively few individuals who
will develop the disease given the exposure. Sec-
ond, the incubation period from exposure to onset
may be very long-measured in years, rather than
days. The population must therefore be followed
for long periods of time or we must resort to the
classical historical perspective types of study de-
signs. The so-called historical perspective study is
plagued by the inability to clearly define the
exposure dose, especially for many of the long
Environmental Health Perspectivesincubation period diseases. The criteria for the
measurement of exposure many years ago is often
the basis of the argument about low dose effects.
The third basic problem is related to the attribut-
able risk estimations for most of the common
diseases, such as lung cancer, heart attack and
stroke and many ofthe other chronic diseases. The
majority of the diseases have multiple etiologies
other than the environmental agent. The attribut-
able risk associated with the environmental expo-
sure may be small. The relatively low attributable
risk percentage results in a small difference in
incidence of disease between the potentially ex-
posed population and suitable controls and an even
smaller difference within the exposed cohort. Only
when the relative risk is high and the cohort
exposed is fairly well defined, is it generally
possible to clearly identify the epidemic related to
the environmental exposure. Unfortunately, such
situations generally apply to relatively high dose
effects rather to the more common low dose effects
of community environmental exposures. Unfortu-
nately in many situations we are searching for a
10% or may be 50% increase in risk following
exposure, that is a relative risk of may be 1.1 to
1.5. This small relative risk plus the low attribut-
able risk previously mentioned requires a very
large sample size for study (Table 2). Sample size
and long incubation period require considerable
costs for followup. Yet we could argue that a 10%
excess risk associated with a very high prevalence
of the environmental exposure could result in a
substantial increase in the number of cases of a
disease in a population.
Unfortunately, to make matters even more
difficult, the exposure is often confounded by
differential exposure to other risk factors. The
population at risk (exposed) may have characteris-
tics that also increase the risk of the disease of
interest. For example, the distribution ofcigarette
smoking, air pollution and specific occupational
exposures may all cluster within certain low socio-
economic and so called blue collar populations
Table 2. Estimated sample size forcohort study a = 0.05 (two
sides) and 13 = 0.05 for relative risk of 1.5, based on various
estimates of incidence of disease in "now exposed."
Incidence Sample size each group
5/1000 25,755
10/1000 12,795
20/1000 6,315
30/1000 4,155
50/1000 2,427
1/100 1,131
3/100 267
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(Table 3). The ability to separate air pollution from
occupational exposures and cigarette smoking and
risk of lung cancer or chronic obstructive pulmo-
nary disease has been extremely difficult (Fig. 1).
In order to reduce the cost of these studies,
investigators have presumed that the distribution
of these confounding variables, such as occupation
and cigarette smoking, are similar among those
environmentally exposed and not exposed. Their
solution to the problem is to either not measure
the confounding variables or do it so crudely as to
result in a meaningless measurement.
Several solutions to these problems have been
suggested. The first, as proposed by Dr. Enterline
and others, is to study primarily occupational
groups that have much higher levels of exposure
and greater ease of followup. If an excess of a
disease is identified in these occupational groups,
then studies of the general population, that is,
nonoccupationally exposed and therefore presum-
ably at lower dose, would be considered, or some
mathematical model would be developed to relate
high to low dose exposures. I would tend to agree
that the occupational studies have a better defined
population, have greater exposure, and may well
be the first line of study. There are several
problems with this approach. The sample sizes in
many occupational studies are too small to identify
the risk associated with some of the less common
types of diseases especially some of the cancers
(Table 4). Rarely have the occupational longitudi-
nal studies been able to identify a disease risk not
previously identified from either clinical or case
control studies. The longitudinal occupational stud-
ies therefore tend to be more verification than the
identification of new environmental exposures.
There may be more susceptibles in the general
population, such as women, children, elderly, or
those with other chronic diseases who may be at
risk to an exposure that would not be observed in
an occupational setting. For example, Aronow (4)
has proposed that low dose carbon monoxide
exposures are associated with decreased exercise
Table 3. Age-adjusted cigarette smoking rates for white male
residents ¢ 35 years of age of Lawrenceville and the South
Hills, 1978.a
Never Ex- Current
smoked, % smoker, % smoker, % Total, %
Lawrenceville 21.9 31.3 46.8 100
South Hills 34.1 38.8 27.1 100
Difference 12.2b 7.5C 19.7b
aData ofWeinberg (1).
bSignificant at 0.1% level.
CSignificant at 1% level.
83Table 4. Probability of developing site-specific cancer in 20
years: white men, age 50.
Sample size detect
Probability, %a a 1.5 relative riskb
All cancers 13.9 805
Lung cancer 3.8 3,536
Colon and rectum
cancer 2.2 7,261
Prostate cancer 1.7 9,744
Bladder cancer 1.0 14,711
Stomach cancer 0.5 29,610
Leukemia 0.4 37,060
aData of Seidman (2).
bo = 0.01, I = 0.10; data of Schlesselman (3).
tolerance among patients with severe angina pec-
toris. Studies of occupational groups exposed to
high levels of carbon monoxide, let us say 50-75
ppm, may not demonstrate any health effects
because of the absence of patients with angina
pectoris from this cohort, or the fact that such
patients are relatively few in the occupational
setting and would not be identified by the usual
followup techniques. In spite of these limitations,
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the use of the occupational cohort studies should
not be minimized.
Another approach is to select sentinels of dis-
ease. In the classical epidemiological common source
epidemics, such sentinels of disease may be specific
types of bacteria, such as the typing of Salmonella
or Shigella. A common serotype among those with
disease or subclinical disease and also at the
environmental source is a valuable and powerful
measurement of an environmental exposure. In
the current environmental epidemiological studies
it is some times useful to identify diseases which
are relatively rare or have unusual pathologic
characteristics as a sentinel of exposure to specific
environmental agents, such as mesothelioma in
relationship to asbestos exposure and angiosarcoma
in relationship to vinyl chloride. Even though
these diseases are rare, we might consider that
any individual with the disease belongs to the
"epidemic" cohort, and that study ofthese individ-
uals may identify other sources of environmental
exposure. Similarily, other investigators have sug-
gested using other specific markers such as chro-
mosomal aberration or biochemical measurements
(1) .
.(18)
(9) (27)
(28)
(30)
6,000 7,000 8,000 9,000 10,000
Median Income
FIGURE 1. Plot of white male lung cancer incidence rates by median income for geographic
Pennsylvania, 1970. Numbers in parentheses are area numbers. Correlation coefficient = 0.6109.
areas of Allegheny County,
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84rather than specific diseases as an indicator of
exposure. The increased prevalence of a marker is
not proof of association with disease. The marker
may be present long before clinical disease be-
comes apparent. Identification ofthe marker would
substantially shorten the observed "incubation pe-
riod" necessary for followup, and ifthe prevalence
ofthe marker such as a chromosomal aberration is
much higher than the ultimate disease, leukemia,
the sample size would be substantially reduced.
The cost of the study would be less even if the
specific marker test is relatively expensive.
The great hope for the epidemiologist is the
identification of the steps from exposure to the
biochemical change or cellular change to clinical
disease. Unfortunately the history of the identi-
fication of early markers in relationship to subse-
quent disease has not been promising. Thus, in
recent years, sputum cytology, CEA antigen and
a-fetoprotein have not been as sensitive and specific
as initially predicted.
The second question is, who pays the cost? The
shrinking health research dollar and the inflationary
costs of studies will certainly result in a decrease
in both the number and scope of future investiga-
tions.
A large number of studies are being supported
by other than the usual federal health research
sources (Table 5). These include: (1) single indus-
try or company financed occupational studies, (2)
support from industry wide trade organization,
such as the Electric Power Research Institute and
the National Egg Board, (3) studies by founda-
tions, and (4) studies initiated by labor unions and
other consumer organizations.
Financial support for environmental research
from any of these sources have certain restric-
tions. Industry support is obviously goal-specific.
The industry or company, such as a steel company,
is interested in determining the potential health
Table 5. Funding of environmental research and studies.
Source Problem
Industry Short-term, limited population;
specific goal-directed; potential
bias
Trade organizations Short-term; specific goal-directed;
bias
Foundations Limited support; time restrictions
Labor unions and Short-term, limited population;
consumer groups specific goal-directed; potential
bias
Federal and state Political realities of less money
government and competition; high cost of
environmental studies; may be
insufficiently goal-directed
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hazards related to a specific exposure within the
industry. The recent explosion in industrial epi-
demiological studies seems to be generated by a
desire to stay at least one step ahead of NIOSH
and OSHA regulations and the numerous criteria
statements which are being published. Excellent
industry-supported studies have been done espe-
cially here at the Graduate School ofPublic Health
in the Department of Biostatistics and Industrial
and Environmental Health Sciences. Unfortunately
the support of these studies is some times predi-
cated on the interest of the company and not
necessarily on the specific merits of the issues.
Most of these studies have also been limited in
their scope to reviews of occupational records and
mortality followup. Recently there has become a
tendency for companies to acquire their own "in-
house epidemiologist" as a way of better control-
ling the output and cost. Such an approach, if it
continues, could clearly lead to biased studies
whether intended or not. Few ofthese studies will
probably expand beyond the company population,
due to publication restrictions once a particular
problem with these studies has been deduced, at
least in those studies being conducted by univer-
sity groups.
Support ofresearch by so called industrial trade
organizations is also apparently growing in popu-
larity. The "consumer" or industrial producer is
taxed a smaller amount of money which is then
marked for research usually related to the indus-
trial product. The Electric Power Research Insti-
tute apparently has a small hidden tax on electric
bills. The National Egg Board collects money
based on the shipments of crates of eggs. This
approach to collecting research funds has certain
merits that will be discussed later. A relatively
large amount of funds can be generated at a
minimal cost to any single individual. The funds
can generally be utilized for goal-directed impor-
tant research of particular interest to both the
company and the consumer. The basic problem
again is that this type ofresearch tends to be very
goal-specific as defined by the industrial organization
and is often tailored to the specific value of the
products. The Egg Board research, for example,
has come under considerable scrutiny because of
the belief that the research is primarily aimed at
proving the value of the egg yolk. It is unlikely
that the research supported by the Electric Power
Research Institute is oriented primarily at turning
on light switches. However, the research is generally
not investigator-oriented and therefore in some
way may stifle the intellect of the investigative
research community. Also this research tends to
be short term as compared to the necessary long
85term epidemiological studies often necessary for
major environmental problems.
The foundations have played a role in public
health research and teaching. The Rockefeller
Foundation was responsible for the early devel-
opment of public health schools in the United
States. The work of the National Foundation for
Infantile Paralysis in the development of the Salk
vaccine is well known. The Mellon Foundation
supported the development of the University of
Pittsburgh Graduate School of Public Health. Foun-
dation support will probably continue to play a
vital role in public health and in environmental
research. However, foundation support is often
short term and subject to the vagaries of the
"board of directors" or review committee.
Finally, pressure from labor unions and con-
sumer organizations has resulted in another source
ofsupport for environmental research. In this case
as part of a labor agreement a certain amount of
funds are set aside for research into a specific
problem. Again, the research is very goal-specific,
often related to a specific company or industry,
and not a general environmental problem.
The above sources of research support will
continue to play a major role in environmental
research. I believe, however, that the major
source of support will continue to depend on the
federal research program, such as the National
Institutes of Health, Environmental Protection
Agency, and the National Institute of Occupation,
Safety and Health. There are several reasons for
these assumptions. First, as noted, much of the
funds from the other sources are generally re-
stricted to specific industry and occupational groups.
Second, are usually very goal specific, that is a
contract to do a specific job, and thirdly, of
relatively short duration. It is doubtful whether
major environmental research programs within
universities, or other health centers can survive
strictly on such funds.
Continued federal support for our environmental
epidemiological research is obviously related to the
quality of the research proposals and the availabil-
ity ofthe funds. Two aspects ofstudy designs have
recently created very thorney problems for the
support ofthese studies.
The first problem has also been previously
discussed and relates to the inability to measure
the individual's exposure. Many of the earlier
environmental studies were ofthe so-called ecolog-
ical type, in which the distributions ofrates within
a community or over time were compared in
relationship to estimated environmental exposures.
As noted, it is unlikely that such studies will
resolve the low dose-effect problem. They are all
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confounded by numerous other differences between
the communities, as well as difficulties in estimat-
ing doses within defined populations. The occupa-
tional longitudinal studies have also provided rela-
tively crude estimates of exposure dose. Support
for future epidemiological studies of low dose
effects will probably require a better estimate of
environmental exposure especially low dose ef-
fects. This will include more careful measurements
of the occupational, community, and home envi-
ronmental exposures. Occupational epidemiological
studies will require good industrial hygiene mea-
surement. Better estimates of air and water pollu-
tants will be required, and at least some sampling
by personal monitoring of the environment will
probably be necessary. The measurement of the
home environment that is indoor pollution will
probably be an extremely difficult and complex
problem.
The second concern has also been briefly men-
tioned in the introduction. Studies of low dose
effects, even with relatively large sample sizes and
adequate power, have a good chance of failing to
demonstrate any adverse effect (Table 4). Some
investigators seem to panic at the thoughts of an
expensive "negative" study. One federal agency
has gone as far as to basically decide that negative
epidemiological studies are of little value. Basical-
ly, if you don't have a positive result you're fired!
Scientific review groups responsible for allocation
of funds are not easily disposed to supporting low
dose effect studies that have a high probability of
finding no effects. It does seem to me that there is
an important place for such studies. Many citizens
are frightened by the potential health effects of
low level environmental exposure. For example,
small increases in radiation exposure, such as been
noted in Cannonsburg, near Pittsburgh, or in
relationship to Three Mile Island, have conjured
up the fear of many cases of leukemia, cancer,
congenital malformations and developmental ab-
normalities. Some individuals feed this fear with
inaccurate data and numerous press reports. News-
paper reporters unable to obtain data from avail-
able studies often publish preliminary and inaccu-
rate information and add to the citizens' concern.
The hysteria associated with the reporting of the
exposure probably has a far greater health effect
on the public than the potential low dose physical
effect. The ability to determine clearly the esti-
mated health impact from low dose effect would be
extremely important for the physical as well as
mental health ofthe population. The study designs
to test these low dose effects must be biologically
sound. The length of followup has to be adequate
to cover the proposed incubation period. The
Environmental Health Perspectivesestimation of dose must be reasonably determined
both within the exposed population and between
the exposed and controls. The sample size should
be large enough given an estimated relative risk to
have at least a reasonably good power. The
relative risk estimates should be based on the best
current available data.
These studies are very expensive and I believe
will not be supported by currently available fed-
eral research dollars. We will therefore be left
with three choices: (1) to accept the fact that low
dose epidemiological studies are not cost-effective
and accept toxicological, animal experimental and
the mathematical extrapolation from high dose
studies in humans, (2) to modify the epidemiologi-
cal research methodology to reduce cost but still
have studies reasonably capable ofobtaining useful
information, and (3) to develop other sources of
funding.
As an epidemiologist and public health physician,
I would have a hard time accepting the first
premise. Other scientist seem to agree. The possi-
bility of errors is very large; and some effects can
only be measured in man. There are great difficulties
in measuring low dose effects by animal experi-
mental studies and toxicological studies. The world
is not divided into good and bad environmental
effects. There is a critical grey zone that requires
careful studies in man. Possibly we should return
to the more classical common source type of
investigation, rather than the more extensive
longitudinal studies that begin with environmental
exposure and proceed to disease. There would
obviously be exceptions to this sequence. Conceiv-
ably the great cost of environmental studies would
be reduced if the investigators followed the usual
track of common source epidemics and began with
disease outbreaks. Improved surveillance of so-
called "long incubation period" diseases, such as
cancer, heart disease, congenital malformation,
developmental abnormalities, and other diseases
may increase the likelihood of identifying specific
epidemics. Surveillance specifically aimed at rare
cancer sites or occurrence at unusual ages such as
the young adult within selective communities with
subsequent followback to determine potential en-
vironmental sources may be a more feasible ap-
proach. Changes in the prevalence or incidence of
a specific developmental abnormality in relation to
time or place, may be related to an environmental
exposure. The Atlanta Congenital Malformation
Registry has recently noted an apparent epidemic
of ventricular septal defects. Other investigators
have utilized the study of chromosomal aberration
among both spontaneous and induced abortions as
markers of environmental exposure. These surveil-
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lance systems require: (1) the identification of an
epidemic, that is an increase in the frequency of a
disease as compared to changes in reporting or
ascertainment; (2) careful followback studies to
identify the possible environmental and occupa-
tional exposures (which may be particularly difficult
in long incubation period diseases) and (3) followup
industrial hygiene studies to determine the poten-
tial exposure doses. This approach is similar to a
classical common source epidemic investigation.
Again the basic difference is in relation to the
incubation period and the type of exposure.
One ofthe growing problems with these types of
studies is the confidentiality questions that are
increasingly limiting the investigators to the avail-
able data sources, such as mortality statistics,
incidence data, hospital records, birth certificates,
etc. One always wonders how John Snow would
have responded if the water company and health
department had told him that their records were
confidential. We recently had an experience in
which the gas company told us that the date in
which a home was switched from coal burning to
natural gas was confidential.
Finally, a more adequate source of funding is
necessary. If it is logical to tax the consumer for
electric power and use the funds to support the
Electric Power Research Institute, and for the
Egg Board to tax each crate of eggs, then
producer-related health research taxes might be
considered. The obvious approach would be a tax
on the sources of environmental pollution or on
known health hazards. A tax on certain industrial
processes known to cause pollution in the envi-
ronment might be considered inflationary and also
likely to decrease the competitive position of an
American industry. The steel industry is reported
to be in deep trouble already and would probably
be quite unhappy if an additional tax were added
to their product, even if relatively modest, espe-
cially if the funds were used for research not
directly related to the industry. The use of fines
for pollution as a source of health research would
be unstable and also might lead to more enforce-
ments in order to obtain more money. The old
speed trap towns would be replaced by the envi-
ronmental monitoring patrol.
A tax on dangerous consumer products would
have certain appeal (Table 6). Cigarette smoking is
probably the single largest source of personal
environmental pollution. Representative Drinan
recently introduced legislation to add a 10 cent tax
to cigarettes. He estimated a yield of about
$4-5,000,000,000. My own estimates which were
conceived prior to his announcement were more
conservative, about $2,500,000,000. He apparently
87Table 6. Estimated yield from atax on cigarettes and alcohol.
Source
Cigarette Estimated cigarette
smokers 85,000,000
Smoking Average 1 pack/day 85,000,000
Packs per year x 365 31,025,000,000
Tax 1Oe per pack = $3,102,000,000
Alcohol Estimated alcohol
consumption 2.68 gallons per capita
Adult population, : 17 155,452,000
Total consumption 416,611,360 gallons
Tax at $1/gallon $416,611,360
Oz/gallon 128
Oz/drink 0.5
Tax per drink 0.3o
Tax at lo/drink = $1,372,800,000
proposes the use of such funds for both health care
and research. I think a more realistic use of such
funds would be for health-related research. The
unfortunate victim ofsmoking related diseases will
probably benefit more from health research than
payment for ineffective treatment.
Excess consumption of alcohol along with ciga-
rette smoking are the major sources of many
diseases in this country. The estimated revenue
from a $1 tax based on a gallon of alcohol would be
$500,000,000 per year. This would be the equiva-
lent ofa 0.2 cent tax on a bottle ofbeer. These two
sources of funding could lead to a major expansion
of public health efforts in the United States. They
could lead to a better understanding of the rela-
tionship between various environmental factors,
health and disease.
In summary, changes in environmental epidemi-
ological research are necessary. These include: (1)
support for primary investigator initiated research,
(2) better measurement of the environment and
disease, (3) great emphasis on case-control and
investigations of epidemics and (4) a better and
more stable source of funding.
REFERENCES
1. Weinberg, G., Kuller, L., and Redmond, C. The relationship
between the geographic distribution oflung cancer incidence
and cigarette smoking in Allegheny County, Pennsylvania.
In press.
2. Seidman, H. Probability of eventually developing and dying
of cancer. Cancer J. Clinicians 28: 33 (1978).
3. Schlesselman, J. (Biometry Branch, Institute of Child
Health and Development). Personal communication.
4. Arnow, W. S. The effect ofcarbon monoxide on cardiovascu-
lar disease. Preventive Med. 8: 271-278 (1979).
88 Environmental Health Perspectives